PCI prepares for Brexit with Irish facility investment

Dublin site will be a primary and secondary packaging, storage, logistics and distribution centre to support European expansion and continuity of supply

New Dublin, Ireland, facility

PCI Pharma Services has reinforced its position in the EU with a strategic investment to deepen its presence in Ireland and expand its European foothold.

The biopharmaceutical CDMO has invested in a new dedicated state-of-the-art clinical facility near Dublin, Ireland which will significantly increase capabilities and capacity for its Clinical Services business as a part of its overall global network expansion strategy.

On completion, the building will provide more than 75,000 sqft of space, serving as a key primary and secondary packaging, storage, logistics and distribution centre. The expansion will take place over the coming months and will bring additional controlled room temperature and cold chain storage capabilities for PCI customers, as well as clinical packaging services.

This new investment will complement PCI’s already established footprint in Dublin, Ireland following the acquisition of Millmount Healthcare in 2017. The facility, which is licensed by HPRA, also offers clinical storage and distribution (S&D) for the shipment of Investigational Medicinal Products (IMP) to sites based both within the EU and globally. Additional services at the site include cold chain handling, packaging and storage capabilities for clinical and commercial products and serialisation capability as well as a full analytical release testing laboratory.

Since the acquisition/establishing its presence in Ireland, PCI has debuted a state-of-the-art dedicated high containment packaging facility specialising in commercial primary and secondary packaging for all solid oral dose forms including specialised and high potent products.

Commenting on this latest investment, Salim Haffar, PCI CEO, said: “Our growth strategy is focused on the continued expansion of our global network to support growing demand from our customers and providing a solution for Brexit through ongoing investment in capacity, capability expansion and talent.”

This new investment in Ireland complements PCI global clinical network in Bridgend, UK, Rockford and San Diego, US and Melbourne, Australia sites, with mirrored capabilities.

Companies